Brunswick director awarded 740 deferred shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BRUNSWICK CORP director David C. Everitt received a grant of 740 deferred shares of common stock on 2026-07-31 at $79 per share. These deferred shares are deposited in his director deferred account and will be distributed in predetermined installments after he ceases being a director, bringing his direct holdings to 39,908 shares, including 203 shares acquired through dividend reinvestments through June 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 740 | $79.00 | $58K |
Footnotes (2)
- F1. Deferred shares deposited in the director's deferred account, which will be automatically distributed in predetermined installments after the director ceases being a director of the Company.
- F2. Beneficial holdings include 203 shares acquired pursuant to dividend reinvestments through June 2026.
Key Figures
Key Terms
dividend reinvestments financial
beneficial holdings financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Brunswick (BC) director David C. Everitt report?
Does David C. Everitt’s Brunswick (BC) holding include dividend reinvestments?
AI-generated analysis. How Rhea-AI works. Not financial advice.